CNN: Moderna's clinical trial numbers show there's 'no way' Trump can have a vaccine by Election Day
UC expert leading local trial is encouraged by community response
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, is featured in an article by CNN on the trial of the Moderna vaccine for COVID-19. In the story, Peter Hotez, MD, a vaccinologist at Baylor College of Medicine and CNN medical expert, says there is "no way" the vaccine will be ready by Election Day Nov. 3 as President Trump is hoping.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum, who is the medical director for the Moderna trial at UC, told CNN he expects to start enrolling patients at his site in the middle of August. He said his goal is to enroll 500 patients, and already 2,500 patients have reached out to him inquiring about the trial.
"We're getting good numbers," he said of the trial. "I think this accrual is going to hit its target pretty quickly."
Read the entire story here.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.